![]() |
||||||||
OVERVIEW OF ACTIVITY
Breast cancer is one of the most rapidly evolving fields in medical oncology. Published results from clinical trials continuously lead to the emergence of new therapeutic agents and changes in the indications for existing treatments. In order to offer optimal patient care, the practicing medical oncologist must be well informed of ongoing and proposed clinical research opportunities, as these offer meaningful therapeutic options to many patients. This CME program is intended to inform and update medical oncologists on clinical trials of biologic agents in breast cancer and to encourage their enrollment of appropriately selected patients in these studies.
LEARNING OBJECTIVES
ACCREDITATION STATEMENT
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Research To Practice designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
HOW TO USE THIS CME ACTIVITY
TThis CME activity contains a print component. To receive credit, the participant should review the CME information, review the monograph and complete the Post-test and Educational Assessment and Credit Form located in our website at ResearchToPractice.com/BCU/SABCSTrials. ResearchToPractice.com/BCU/SABCSTrials includes an easy-to-use, interactive version of this monograph with links to relevant full-text articles, abstracts, trial information and other web resources indicated here in blue underlined text.
This program is supported by educational grants from Genentech BioOncology and Pfizer Inc.
EDITOR'S NOTE
Bail Us Out
Neil Love, MD
CLINICAL TRIALS
Neoadjuvant Therapy
Adjuvant Therapy
Metastatic Disease
Breast Cancer
Clinical Trials Guide:
A CME Audio Series and Activity